In this issue:
- Oral contraceptives and risk of liver cancer
- Treatment patterns and outcomes in US patients with early-stage HCC
- TACE alone or combined with ICI and TKI therapy in patients with unresectable HCC
- Sex differences in risk of adverse liver events in patients with cirrhosis
- Causes of mortality among patients with early-stage HCC
- Perioperative therapy in locally advanced GBCs
- Neoadjuvant chemotherapy in resectable biliary tract cancer
- External-beam radiation therapy in HCC
- Management of portal vein tumour thrombosis in HCC
- How can we eliminate HCC from NZ?
Please login below to download this issue (PDF)